BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 19616029)

  • 1. Molecular basis of human immunodeficiency virus drug resistance: an update.
    Menéndez-Arias L
    Antiviral Res; 2010 Jan; 85(1):210-31. PubMed ID: 19616029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of human immunodeficiency virus type 1 drug resistance: overview and recent developments.
    Menéndez-Arias L
    Antiviral Res; 2013 Apr; 98(1):93-120. PubMed ID: 23403210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: a review of the last 20 years (1989-2009).
    de Béthune MP
    Antiviral Res; 2010 Jan; 85(1):75-90. PubMed ID: 19781578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical management of HIV-1 resistance.
    Paredes R; Clotet B
    Antiviral Res; 2010 Jan; 85(1):245-65. PubMed ID: 19808056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fifteen years of HIV Protease Inhibitors: raising the barrier to resistance.
    Wensing AM; van Maarseveen NM; Nijhuis M
    Antiviral Res; 2010 Jan; 85(1):59-74. PubMed ID: 19853627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming resistance to existing therapies in HIV-infected patients: the role of new antiretroviral drugs.
    Perno CF; Moyle G; Tsoukas C; Ratanasuwan W; Gatell J; Schechter M
    J Med Virol; 2008 Apr; 80(4):565-76. PubMed ID: 18297706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on HIV resistance and resistance testing.
    Sebastian J; Faruki H
    Med Res Rev; 2004 Jan; 24(1):115-25. PubMed ID: 14595674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-resistant human immunodefiency virus.
    Kozal MJ
    Clin Microbiol Infect; 2009 Jan; 15 Suppl 1():69-73. PubMed ID: 19220361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV type 1 integrase inhibitors: from basic research to clinical implications.
    Jegede O; Babu J; Di Santo R; McColl DJ; Weber J; Quiñones-Mateu M
    AIDS Rev; 2008; 10(3):172-89. PubMed ID: 18820719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and biochemical effects of human immunodeficiency virus mutants resistant to non-nucleoside reverse transcriptase inhibitors.
    Domaoal RA; Demeter LM
    Int J Biochem Cell Biol; 2004 Sep; 36(9):1735-51. PubMed ID: 15183341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genotypic antiretroviral resistance testing and phylogenetic analysis of protease and reverse transcriptase in antiretroviral drug-naïve AIDS patients in Henan province].
    Yang K; Li JY; Bao ZY; Li HP; Li L; Zhuang DM; Wang Z; Li H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 May; 26(5):351-5. PubMed ID: 16053762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral resistance among HIV-infected persons who have died in British Columbia, in the era of modern antiretroviral therapy.
    Recsky MA; Brumme ZL; Chan KJ; Wynhoven B; Yip B; Dong WW; Heath KV; Montaner JS; Levy AR; Hogg RS; Harrigan PR
    J Infect Dis; 2004 Jul; 190(2):285-92. PubMed ID: 15216463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 resistance to first- and second-generation non-nucleoside reverse transcriptase inhibitors.
    Ghosn J; Chaix ML; Delaugerre C
    AIDS Rev; 2009; 11(3):165-73. PubMed ID: 19654858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New anti-HIV agents and targets.
    De Clercq E
    Med Res Rev; 2002 Nov; 22(6):531-65. PubMed ID: 12369088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status and challenges of antiretroviral research and therapy.
    Esté JA; Cihlar T
    Antiviral Res; 2010 Jan; 85(1):25-33. PubMed ID: 20018390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strand transfer inhibitors of HIV-1 integrase: bringing IN a new era of antiretroviral therapy.
    McColl DJ; Chen X
    Antiviral Res; 2010 Jan; 85(1):101-18. PubMed ID: 19925830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and structural analysis of HIV-1 integrase conservation.
    Ceccherini-Silberstein F; Malet I; D'Arrigo R; Antinori A; Marcelin AG; Perno CF
    AIDS Rev; 2009; 11(1):17-29. PubMed ID: 19290031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular mehanisms of drug resistance acquisition in HIV].
    Sugiura W
    Nihon Rinsho; 2009 Jan; 67(1):43-51. PubMed ID: 19177751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.